UNSPSC 51386614: Collagen/polyvinylpyrrolidone

Collagen-polyvinylpyrrolidone (C-PVP) is a copolymer that is generated from the ? irradiation of a mixture of type I collagen and low-molecular-weight PVP

UNSPSC 51386614 Collagen/polyvinylpyrrolidone is a Commodity code. The recent state and local opportunities tagged to this code show minimal relevant procurement activity; of the nineteen records in the dataset, only two address pharmaceutical or medical-supply procurement with any substantive connection to the code's nominal scope, and neither explicitly solicits collagen or polyvinylpyrrolidone products. The City of Tucson Fire Department's RFP 260217 for BLS/ALS pharmaceuticals, supplies, and vending machines (response deadline June 24, 2026) and Seminole County, Florida's IFB 60459723LAS for naloxone and drug deactivation systems (response deadline July 26, 2023) represent the clearest pharmaceutical procurement activity in the dataset, but neither mentions collagen or polyvinylpyrrolidone specifically. The remaining records—vendor forums, reverse trade shows, networking events, and surveys across Williamson County (Texas), Marion County (Florida), Indian River County (Florida), Collin County (Texas), Pasco County (Florida), and other jurisdictions—are business-development outreach rather than formal solicitations for specific goods. A cooperative purchasing contract issued by the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) for generic multi-source pharmaceuticals and OTC products (RFP S1070000015802, response deadline March 26, 2026) includes pharmaceutical distribution but does not identify collagen or polyvinylpyrrolidone among its scope.

The code shows no concentrated geographic activity and no repeat issuing bodies aligned with collagen or polyvinylpyrrolidone procurement. The pharmaceutical and medical-supply activity visible in the dataset—primarily in Arizona, Florida, Arkansas, and Minnesota—targets emergency medical services, fire departments, forensic laboratories, and behavioral health agencies, with scope focused on emergency pharmaceuticals, oxygen delivery, naloxone, drug reference standards, and general medical supplies rather than wound-care or dermatological products. No evidence supports active or recent state and local demand for collagen or polyvinylpyrrolidone products under this code. Business development professionals should monitor broader pharmaceutical and wound-care categories or specialized dermatological and surgical-supply codes rather than expect near-term opportunities under this classification.